7Baggers
Quarterly
Annual
    Unit: USD2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 
      
    		                   
      operating activities
    		                   
      net income
    		7,007,000 150,098,000 -15,345,000 1,328,000 6,286,000 9,377,000 10,400,000 -3,536,000 -4,626,000 -4,464,000 -4,470,000 -4,653,000 -3,649,000 -3,981,000 -2,984,000 -2,542,000 -3,763,000 -3,885,000 -4,272,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      depreciation and amortization
    		19,352,000 21,004,000 21,010,000 21,347,000 22,368,000 22,793,000 22,881,000 23,553,000 24,860,000 24,208,000 22,691,000 19,658,000 18,305,000 16,902,000 15,777,000 14,826,000 13,985,000 13,520,000 14,097,000 
      straight line rent adjustment
    		-208,000 -251,000 -17,000 1,044,000 -15,000 -111,000 -216,000 -637,000 -1,319,000 -904,000 -822,000 -974,000 -966,000 -1,146,000 -614,000 -510,000 -492,000 -443,000 -518,000 
      intangible amortization in rental revenue
    		-292,000 -294,000 -299,000 -293,000 -318,000 -401,000 -417,000 -519,000 -541,000 -545,000 -1,546,000 -507,000 -480,000 -615,000 -494,000 -640,000 -449,000 -438,000 -548,000 
      amortization of debt related costs
    		599,000 563,000 470,000 438,000 438,000 476,000 570,000 566,000 565,000 527,000 505,000 442,000 424,000 370,000 369,000 416,000 386,000 366,000 299,000 
      loss on financing transaction
    		                   
      stock based compensation
    		1,134,000 1,079,000 1,093,000 1,111,000 914,000 838,000 827,000 1,105,000 518,000 538,000 442,000 340,000 340,000 461,000 418,000 383,000 324,000 383,000 349,000 
      gain on sale of real estate
    		-301,000   -849,000 -8,030,000 -10,534,000      -1,185,000 0 0 -590,000     
      unrealized gain from interest rate swap
    		-131,000                   
      loss in investment of unconsolidated joint ventures
    		8,048,000                   
      changes in operating assets and liabilities:
    		                   
      other assets
    		1,315,000 7,313,000 -9,027,000 -2,150,000 1,785,000 -3,679,000 -1,007,000 -2,075,000 14,000 784,000 362,000 2,837,000 -7,426,000 -814,000 1,520,000 -3,476,000 -520,000 1,952,000 -7,570,000 
      deferred leasing costs
    		-793,000 -1,132,000 -2,113,000 -759,000 -1,043,000 -1,994,000 -1,588,000 -1,352,000 -2,209,000 -1,459,000 -648,000 -2,201,000 -1,260,000 -2,143,000 40,000 -814,000 -968,000 61,000 -517,000 
      accounts payable, accrued expenses and other liabilities
    		-6,033,000 15,779,000 6,905,000 -1,354,000 -5,771,000 1,848,000 4,350,000 -3,729,000 5,931,000 2,686,000 -2,789,000 5,626,000 1,538,000 1,918,000 843,000 3,310,000 1,305,000 2,749,000 4,966,000 
      net cash from operating activities
    		15,612,000 42,025,000 17,568,000 19,863,000 16,614,000 18,613,000 23,760,000 13,376,000 23,193,000 21,371,000 14,288,000 23,393,000 7,930,000 11,812,000 14,805,000 10,972,000 10,222,000 14,265,000 6,286,000 
      investing activities
    		                   
      acquisition of real estate properties
    		-65,692,000 -20,656,000      0 -16,810,000 -49,144,000 -131,131,000 -170,656,000 -90,351,000 -14,551,000 -61,472,000 -105,855,000    
      real estate improvements
    		-4,269,000 -7,729,000 -7,162,000 -5,575,000 -3,760,000 -8,209,000 -8,022,000 -15,807,000 -22,223,000 -11,148,000 -6,316,000 -9,678,000 -7,912,000 -5,915,000 -1,803,000 -1,485,000 -1,359,000 -1,346,000 -1,873,000 
      proceeds from the sale of real estate
    		                   
      net investment in sales type lease
    		                   
      net cash from investing activities
    		-67,773,000 175,664,000 -87,390,000 2,928,000 -3,739,000 8,232,000 10,209,000 -15,807,000 -39,033,000 -60,070,000 -137,447,000 -176,280,000 -98,263,000 -20,466,000 -61,071,000 -114,042,000 -52,804,000 -1,403,000 -90,869,000 
      financing activities
    		                   
      payment from issuance of common stock
    		-23,000                   
      repurchase and retirement of common stock
    		                   
      repayment of secured debt
    		-801,000 -11,523,000 -19,236,000 -2,824,000 -1,306,000 -110,912,000 -8,657,000 -1,565,000 -1,548,000 -1,443,000 -16,630,000 -13,373,000 -1,352,000 -1,339,000 -1,328,000 -82,312,000 -1,298,000 -1,286,000 -1,270,000 
      proceeds from line of credit facility
    		64,500,000 4,009,000    121,900,000 17,500,000 10,000,000 42,000,000 20,000,000 141,000,000 88,000,000 9,000,000 0 42,000,000 90,000,000 0 0 41,500,000 
      repayment of line of credit facility
    		 -180,409,000    -31,500,000  0 -15,000,000 -148,500,000 -10,000,000 -50,000,000 -77,000,000 -30,000,000 -34,000,000 0 -70,100,000 -29,000,000 -21,300,000 
      proceeds from financing transaction
    		 0                  
      proceeds from series c preferred units
    		                   
      financing transaction issuance costs
    		 -2,358,000                  
      debt issuance costs
    		 -6,058,000    -56,000 0 -28,000 -108,000 -1,589,000 -101,000 -1,000    -2,425,000 -155,000 -121,000 -234,000 
      dividends and distributions paid
    		-11,620,000 -11,256,000 -11,013,000 -11,010,000 -10,291,000 -10,292,000 -10,484,000 -10,452,000 -10,241,000 -9,940,000 -9,338,000 -8,955,000 -8,287,000 -7,440,000 -6,795,000     
      net cash from financing activities
    		52,056,000 -207,618,000 67,249,000 -13,899,000 -11,842,000 -30,913,000 -42,214,000 -2,609,000 16,027,000 32,496,000 122,054,000 117,318,000 139,962,000 9,805,000 42,375,000 105,481,000 42,979,000 -25,354,000 103,923,000 
      net increase in cash, cash held in escrow, and restricted cash
    		-105,000 10,071,000 -2,573,000 8,892,000 1,033,000 -4,068,000 -8,245,000 -5,040,000 187,000 -6,203,000 -1,105,000 -35,569,000 49,629,000 1,151,000 -3,891,000 2,411,000    
      cash, cash held in escrow, and restricted cash at beginning of period
    		43,627,000 0 0 0 26,204,000 0 0 0 0 0 43,374,000 0 0 0 32,054,000 0    
      cash, cash held in escrow, and restricted cash at end of period
    		43,522,000 10,071,000 -2,573,000 8,892,000 27,237,000 -4,068,000 -8,245,000 -5,040,000 187,000 -6,203,000 42,269,000 -35,569,000 49,629,000 1,151,000 28,163,000 2,411,000    
      supplemental cash flow disclosures:
    		                   
      cash paid for interest
    		6,127,000 8,873,000 9,940,000 9,395,000 9,337,000 8,762,000 9,235,000 8,286,000 8,057,000 7,278,000 5,310,000 4,815,000 4,441,000 4,484,000 4,432,000 3,979,000 4,321,000   
      assumption of cash, cash held in escrow, and restricted cash upon consolidation of investment in joint venture
    		491,000       0 0 0 2,895,000         
      supplemental non-cash financing and investing activities:
    		                   
      dividends declared included in accounts payable, accrued expenses and other liabilities
    		11,110,000  31,000 37,000 10,938,000               
      distribution payable to non-controlling interest holder
    		118,000 0 0 0 118,000 0 0 0 0 0 108,000 -3,000 0 -15,000 121,000 -14,000 -29,000 -160,000 324,000 
      acquisition of real estate properties included in accounts payable, accrued expenses and other liabilities
    		                   
      financing transaction costs included in accounts payable, accrued expenses and other liabilities
    		5,300,000 -1,706,000                  
      merger transaction expenses included in accounts payable, accrued expenses and other liabilities
    		                   
      real estate improvements included in accounts payable, accrued expenses and other liabilities
    		2,325,000 -1,807,000 1,571,000 805,000 1,232,000 -2,113,000 -69,000 1,736,000 -1,112,000 3,052,000 3,321,000  1,537,000       
      deferred leasing costs included in accounts payable, accrued expenses and other liabilities
    		524,000 -256,000 232,000 11,000 403,000 -1,030,000 557,000 -151,000 -1,175,000 637,000 1,172,000  1,125,000 -1,406,000 1,654,000  -575,000 366,000 391,000 
      consolidation of net book value of investment in joint venture
    		346,000       0 0 0 5,686,000         
      assumption of other assets upon consolidation of investment in joint venture
    		22,000       0 0 0 638,000         
      assumption of accounts payable, accrued expenses and other liabilities upon consolidation of investment in joint venture
    		176,000       0 0 0 1,955,000         
      gain on financing transaction
    		-14,085,000                   
      cash
    		19,126,000  -2,165,000 6,736,000 16,812,000  -6,976,000 -5,338,000 -225,000 -9,044,000 25,610,000 -37,480,000 50,483,000 542,000 12,687,000     
      cash held in escrow
    		818,000  -818,000 2,376,000 3,222,000  -1,355,000 220,000 101,000 2,533,000 10,522,000 1,405,000 -1,178,000 878,000 10,788,000     
      restricted cash
    		23,578,000  410,000 -220,000 7,203,000  86,000 78,000 311,000 308,000 6,137,000 506,000 324,000 -269,000 4,688,000     
      cash, cash held in escrow, and restricted cash
    		43,522,000  -2,573,000 8,892,000 27,237,000  -8,245,000 -5,040,000 187,000 -6,203,000 42,269,000 -35,569,000 49,629,000 1,151,000 28,163,000     
      net investment in sales-type lease
    		 0 21,159,000 64,000 21,000               
      proceeds from sale of real estate
    		2,188,000 208,510,000 0   16,441,000  0 0   4,054,000 0 0 2,204,000     
      loss on extinguishment of debt
    		     0  0 0 0 2,176,000         
      appreciation (depreciation) of warrants
    		                   
      unrealized income from interest rate swap
    		                   
      loss on interest rate swap
    		                   
      contribution to and investment in joint venture
    		                   
      (payment) proceeds from issuance of common stock
    		 -23,000 -207,000 -65,000 -245,000               
      proceeds from issuance of unsecured debt
    		       0 0   50,000,000        
      repurchase of series a preferred stock
    		     0 0 -424,000 -888,000   0 0 0 -12,000     
      redemption of series a preferred stock
    		     -19,000              
      redemption of series b preferred stock
    		       0            
      contribution of cash, cash held in escrow and restricted cash investment to joint venture
    		                   
      dividends declared included in dividends payable
    		     11,000 496,000 -1,000 223,000 317,000 8,887,000 386,000 668,000 861,000 6,371,000 139,000 1,750,000 -2,367,000 6,203,000 
      contribution of real estate properties to joint venture
    		                   
      assumption of secured debt by joint venture
    		                   
      assumption of accounts payables, accrued expenses and other liabilities by joint venture
    		                   
      contribution of other assets to joint venture
    		                   
      contribution to and investment in joint venture in accounts payable, accrued expenses and other liabilities
    		                   
      conversion of common stock warrants
    		       0 0 0 3,758,000         
      series b accretion to redemption value
    		       0 2,371,000 750,000 1,500,000 1,807,000 1,807,000 1,807,000 1,807,000 1,854,000 1,854,000 1,854,000 1,854,000 
      conversion of series b preferred stock
    		       0 36,088,000           
      assumption of secured debt upon consolidation of investment in joint venture
    		       0 0 0 56,000,000         
      (gain) loss on sale of real estate
    		                   
      (earnings) loss in investment of unconsolidated joint venture
    		       0 0 0 147,000  178,000 224,000 273,000     
      proceeds from issuance of common stock
    		     -34,000  -140,000 16,812,000 24,384,000 17,123,000 51,647,000 69,292,000 48,584,000 42,510,000 7,316,000    
      assumption of secured debt
    		           28,800,000        
      impairment on real estate lease
    		               0    
      contribution to and investments in unconsolidated joint venture
    		                   
      proceeds from issuance of secured debt
    		               0 15,000,000 0 81,000,000 
      new financing lease
    		                   
      unrealized appreciation (depreciation) of warrants
    		        0 0 -1,760,000         
      (earnings) loss in investment of unconsolidated joint ventures
    		                   
      supplemental non-cash investing and financing activities:
    		                   
      real estate improvements included in accounts payables, accrued expenses and other liabilities
    		                   
      deferred leasing costs included in accounts payables, accrued expenses and other liabilities
    		                   
      unrealized (appreciation) depreciation of warrants
    		            926,000       
      unrealized appreciation of warrants
    		              247,000     
      fixed asset acquisitions included in accounts payable, accrued expenses and other liabilities
    		              703,000  325,000 -530,000 628,000 
      unrealized appreciation/(depreciation) of warrants
    		               0    
      contribution to and investments in joint venture
    		                   
      fixed asset acquisitions included in accounts payables, accrued expenses and other liabilities
    		                   
      assumption of mortgage notes
    		                   
      dividends paid
    		                -4,956,000 -7,484,000 -6,587,000 
      cash as presented on balance sheet
    		                1,377,000   
      cash held in escrow as presented on balance sheet
    		                -1,418,000   
      restricted cash as presented on balance sheet
    		                438,000   
      cash and cash held in escrow and restricted cash as presented on cash flow statement
    		                397,000   
      change in fair value of warrant derivative
    		                   
      acquisition of properties
    		                 -57,000 -88,996,000 
      proceeds from common stock
    		                 12,537,000 10,814,000 
      net increase in cash and cash held in escrow and restricted cash
    		                 -12,492,000 19,340,000 
      cash and cash held in escrow and restricted cash at beginning of period
    		                 0 22,398,000 
      cash and cash held in escrow and restricted cash at end of period
    		                 -12,492,000 41,738,000 
      interest paid
    		                  4,308,000 
      income from leases
    		                  19,295,000 
      straight-line rent adjustments
    		                  518,000 
      tenant recoveries
    		                  5,868,000 
      amortization of above market leases
    		                  -203,000 
      amortization of below market leases
    		                  751,000 
      total
    		                  26,229,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.